Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T21:39:01.000Z thumbnail image
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value 05 20 7 has been updated to 06 04 8 on the webpage, indicating a recent change in the data related to Medical and healthcare publications and documentation.
    Difference
    1.0%
    Check dated 2024-06-06T14:46:10.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new additions or modifications in the clinical study records or related data elements.
    Difference
    0.3%
    Check dated 2024-05-22T21:37:48.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value 03 27 has been updated to 05 20 on the webpage, indicating a recent change in the study details related to a clinical trial involving Zanidatamab in combination with chemotherapy plus or minus Tislelizumab for patients with HER2-positive advanced or metastatic gastric and esophageal cancers.
    Difference
    0.6%
    Check dated 2024-05-21T16:44:24.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:29:28.000Z thumbnail image

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.